Bianchi M - Search Results

1

Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone.

Bianchi M, Bloom O, Raabe T, Cohen PS, Chesney J, Sherry B, Schmidtmayerova H, Calandra T, Zhang X, Bukrinsky M, Ulrich P, Cerami A, Tracey KJ. Bianchi M, et al. J Exp Med. 1996 Mar 1;183(3):927-36. doi: 10.1084/jem.183.3.927. J Exp Med. 1996. PMID: 8642296 Free PMC article.

2

An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.

Bianchi M, Ulrich P, Bloom O, Meistrell M 3rd, Zimmerman GA, Schmidtmayerova H, Bukrinsky M, Donnelley T, Bucala R, Sherry B, et al. Bianchi M, et al. Mol Med. 1995 Mar;1(3):254-66. Mol Med. 1995. PMID: 8529104 Free PMC article.

3

CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency.

Cohen PS, Nakshatri H, Dennis J, Caragine T, Bianchi M, Cerami A, Tracey KJ. Cohen PS, et al. Among authors: bianchi m. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3967-71. doi: 10.1073/pnas.93.9.3967. Proc Natl Acad Sci U S A. 1996. PMID: 8632999 Free PMC article.

Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production and protect against tissue inflammation and endotoxin lethality [Bianchi, M., Ulrich, P., Bloom, O., Meistrell, M., Zimm …

Recently, a multivalent guanylhydrazone (CNI-1493) developed as an inhibitor of macrophage activation was shown to suppress TNF production a …

4

Spermine inhibits proinflammatory cytokine synthesis in human mononuclear cells: a counterregulatory mechanism that restrains the immune response.

Zhang M, Caragine T, Wang H, Cohen PS, Botchkina G, Soda K, Bianchi M, Ulrich P, Cerami A, Sherry B, Tracey KJ. Zhang M, et al. Among authors: bianchi m. J Exp Med. 1997 May 19;185(10):1759-68. doi: 10.1084/jem.185.10.1759. J Exp Med. 1997. PMID: 9151701 Free PMC article.

5

The tetravalent guanylhydrazone CNI-1493 blocks the toxic effects of interleukin-2 without diminishing antitumor efficacy.

Kemeny MM, Botchkina GI, Ochani M, Bianchi M, Urmacher C, Tracey KJ. Kemeny MM, et al. Among authors: bianchi m. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4561-6. doi: 10.1073/pnas.95.8.4561. Proc Natl Acad Sci U S A. 1998. PMID: 9539777 Free PMC article.

6

High-performance liquid chromatographic method for guanylhydrazone compounds.

Cerami C, Zhang X, Ulrich P, Bianchi M, Tracey KJ, Berger BJ. Cerami C, et al. Among authors: bianchi m. J Chromatogr B Biomed Appl. 1996 Jan 12;675(1):71-5. doi: 10.1016/0378-4347(95)00346-0. J Chromatogr B Biomed Appl. 1996. PMID: 8634770

7

Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493).

Björk L, Tracey KJ, Ulrich P, Bianchi M, Cohen PS, Akerlund K, Fehniger TE, Andersson U, Andersson J. Björk L, et al. Among authors: bianchi m. J Infect Dis. 1997 Nov;176(5):1303-12. doi: 10.1086/514126. J Infect Dis. 1997. PMID: 9359732

8

Fetuin (alpha2-HS-glycoprotein) opsonizes cationic macrophagedeactivating molecules.

Wang H, Zhang M, Bianchi M, Sherry B, Sama A, Tracey KJ. Wang H, et al. Among authors: bianchi m. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14429-34. doi: 10.1073/pnas.95.24.14429. Proc Natl Acad Sci U S A. 1998. PMID: 9826717 Free PMC article.

9

CNI-1493 prolongs survival and reduces myocyte loss, apoptosis, and inflammation during rat cardiac allograft rejection.

Yang X, Szabolcs M, Minanov O, Ma N, Sciacca RR, Bianchi M, Tracey KJ, Michler RE, Cannon PJ. Yang X, et al. Among authors: bianchi m. J Cardiovasc Pharmacol. 1998 Jul;32(1):146-55. doi: 10.1097/00005344-199807000-00023. J Cardiovasc Pharmacol. 1998. PMID: 9676735

10

Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1).

Yang H, Lundbäck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ. Yang H, et al. Mol Med. 2012 Mar 30;18(1):250-9. doi: 10.2119/molmed.2011.00389. Mol Med. 2012. Retraction in: Mol Med. 2020 Dec 30;26(1):133. doi: 10.1186/s10020-020-00264-1. PMID: 22105604 Free PMC article. Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,583 results

Search Page

Filters